Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Imiquimod

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,765Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Taro Pharms Generic Imiquimod Receives Approval In US
    Taro Pharms Generic Imiquimod Receives Approval In US

    31 Jan 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205971

    FDA
    31 Jan 2021
    Share Share
    Risks of Picato for actinic keratosis outweigh benefits
    Risks of Picato for actinic keratosis outweigh benefits

    30 Apr 2020

    // EMA

    https://www.ema.europa.eu/en/news/risks-picato-actinic-keratosis-outweigh-benefits

    EMA
    30 Apr 2020
    Share Share
    Enforcement Report - Week of February 28, 2018
    Enforcement Report - Week of February 28, 2018

    28 Feb 2018

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2018-1519803579.pdf

    FDA
    28 Feb 2018
    Share Share
    New FDA Report Cites 22 Drugs That Passed PhII But Crashed and Burned in PhIII
    New FDA Report Cites 22 Drugs That Passed PhII But Crashed and Burned in PhIII

    21 Jan 2017

    // Mark Terry BIOSPACE

    http://www.biospace.com/News/new-fda-report-cites-22-drugs-that-passed-phase-ii/444652/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews

    Mark Terry BIOSPACE
    21 Jan 2017
    Share Share